Quest Diagnostics (DGX) Cash from Investing Activities (2016 - 2025)
Historic Cash from Investing Activities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to -$201.0 million.
- Quest Diagnostics' Cash from Investing Activities rose 8769.14% to -$201.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$942.0 million, marking a year-over-year increase of 5638.89%. This contributed to the annual value of -$2.5 billion for FY2024, which is 14015.08% down from last year.
- As of Q3 2025, Quest Diagnostics' Cash from Investing Activities stood at -$201.0 million, which was up 8769.14% from -$124.0 million recorded in Q2 2025.
- Quest Diagnostics' Cash from Investing Activities' 5-year high stood at $437.0 million during Q2 2021, with a 5-year trough of -$1.6 billion in Q3 2024.
- For the 5-year period, Quest Diagnostics' Cash from Investing Activities averaged around -$240.6 million, with its median value being -$158.0 million (2023).
- As far as peak fluctuations go, Quest Diagnostics' Cash from Investing Activities skyrocketed by 31317.07% in 2021, and later crashed by 142616.82% in 2024.
- Over the past 5 years, Quest Diagnostics' Cash from Investing Activities (Quarter) stood at -$227.0 million in 2021, then rose by 23.35% to -$174.0 million in 2022, then skyrocketed by 34.48% to -$114.0 million in 2023, then tumbled by 340.35% to -$502.0 million in 2024, then surged by 59.96% to -$201.0 million in 2025.
- Its last three reported values are -$201.0 million in Q3 2025, -$124.0 million for Q2 2025, and -$115.0 million during Q1 2025.